Castle Biosciences CSTL Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$24.16M-232% | $18.25M+132% | -$57.47M+14.4% | -$67.14M-115% | ||
| $40.77M+155% | $16M+29.7% | $12.33M+16.9% | $10.54M+209% | ||
| $45.89M-8.8% | $50.32M-1.8% | $51.22M+41.0% | $36.32M+67.1% | ||
| $64.35M-0.8% | $64.87M— | —— | -$41.66M-119% | ||
| $36.02M+27.2% | $28.33M+108% | $13.62M+142% | $5.63M+61.7% | ||
| —— | —— | -$16.18M+90.3% | -$166.55M-150% | ||
| -$7.06M— | —— | -$2.3M— | —— | ||
| —— | —— | —— | -$206.69M-158% | ||
| $28.33M-22.5% | $36.54M— | —— | -$47.29M-110% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Castle Biosciences generate?
- Castle Biosciences (CSTL) generated $48.3M in operating cash flow over the trailing twelve months.
- What is Castle Biosciences's free cash flow?
- After $43.7M of capital expenditures, Castle Biosciences's free cash flow was $4.5M over the trailing twelve months, down 89.2% year over year.
- Where does Castle Biosciences's cash flow data come from?
- Every line is extracted from Castle Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
